pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
FDA approves flurry of drugs ahead of holiday season
1 day ago · The FDA has followed its usual procedure of wrapping up a series of new drug approvals as the year draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
PBM reform dropped in Congress' funding package
3 days ago · PBM reform looms in end-of-year US legislation package. Legislation that would introduce big changes for pharmacy benefit managers (PBMs) is inching closer to realisation in the US Congress.
About pharmaphorum
3 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
Deep Dive: AI 2024 | pharmaphorum
Dec 11, 2024 · Deep Dive into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and the promise ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Heard on the pipeline: Access to medication - pharmaphorum
Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years. Yet, while discussions have been plentiful, even fruitful, patients around the world still struggle to access treatments.
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
4 days ago · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
News | Timely industry updates for pharma and biotech leaders
pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.